Tissue Repair Ltd has released a press release.
FDA clears TR-987 to progress to Phase 3
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Tissue Repair
- Bank Deposits At SVB Available Tuesday 14 March 2023 AEDT
- Update on Cash Held with Silicon Valley Bank
- Appendix 4D and Half Year Report to 31 December 2022
- TR Pro accepted for peer reviewed journal publication
- FDA Response Clarifies Path to Phase 3 Trials
Later from Tissue Repair
- Appendix 4E and Annual Report 30 June 2023
- Third US Patent granted for Tissue Repair Glucoprime
- Appendix 4D and Half Year Report to 31 December 2023
- TGA approval granted for Tissue Repair TR Pro
- Tony Charara Co-founder appointed as CEO
Follow Tissue Repair into a list and get an email when it puts out news.
Follow Tissue Repair